392 related articles for article (PubMed ID: 23648305)
1. [Neuroendocrine tumors: analysis of 252 cases].
Chi YH; Jiang WC; Du F; Sun YK; Song Y; Yang L; Zhou AP; Wang JW
Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):67-70. PubMed ID: 23648305
[TBL] [Abstract][Full Text] [Related]
2. Advances in the Diagnosis and Management of Well-Differentiated and Intermediate-Differentiated Neuroendocrine Tumors of the Lung.
Wolin EM
Chest; 2017 May; 151(5):1141-1146. PubMed ID: 27373769
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological, treatment, and prognosis study of 43 gastric neuroendocrine carcinomas.
Liu DJ; Fu XL; Liu W; Zheng LY; Zhang JF; Huo YM; Li J; Hua R; Liu Q; Sun YW
World J Gastroenterol; 2017 Jan; 23(3):516-524. PubMed ID: 28210088
[TBL] [Abstract][Full Text] [Related]
4. [Clinicopathological features of colorectal neuroendocrine neoplasms and prognostic significance of WHO staging system].
Zhang XH; Lu XL; Wu N; Liu B; Wang FY; Zhang RS; Zhou XJ
Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):191-6. PubMed ID: 23769440
[TBL] [Abstract][Full Text] [Related]
5. The molecular pathogenesis and management of bronchial carcinoids.
Cakir M; Grossman A
Expert Opin Ther Targets; 2011 Apr; 15(4):457-91. PubMed ID: 21275849
[TBL] [Abstract][Full Text] [Related]
6. Complexity in the treatment of pulmonary large cell neuroendocrine carcinoma.
Kozuki T; Fujimoto N; Ueoka H; Kiura K; Fujiwara K; Shiomi K; Mizobuchi K; Tabata M; Hamazaki S; Tanimoto M
J Cancer Res Clin Oncol; 2005 Mar; 131(3):147-51. PubMed ID: 15538626
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of clinicopathological features of intestinal neuroendocrine neoplasms].
Gao W; Liu SM; Lu HZ; Liang J; Yuan YL; Liu XY
Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):450-6. PubMed ID: 22967448
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathological features of pancreatic neuroendocrine neoplasms: a retrospective analysis of 64 cases].
Yao W; Wang W; Li G
Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):287-93. PubMed ID: 24989916
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in neuroendocrine lung tumors: a Spanish Multicenter Study. Spanish Multicenter Study of Neuroendocrine Tumors of the Lung of the Spanish Society of Pneumonology and Thoracic Surgery (EMETNE-SEPAR).
García-Yuste M; Matilla JM; Alvarez-Gago T; Duque JL; Heras F; Cerezal LJ; Ramos G
Ann Thorac Surg; 2000 Jul; 70(1):258-63. PubMed ID: 10921719
[TBL] [Abstract][Full Text] [Related]
10. A Phase III trial comparing irinotecan and cisplatin with etoposide and cisplatin in adjuvant chemotherapy for completely resected pulmonary high-grade neuroendocrine carcinoma (JCOG1205/1206).
Eba J; Kenmotsu H; Tsuboi M; Niho S; Katayama H; Shibata T; Watanabe S; Yamamoto N; Tamura T; Asamura H; ;
Jpn J Clin Oncol; 2014 Apr; 44(4):379-82. PubMed ID: 24474818
[TBL] [Abstract][Full Text] [Related]
11. [Treatment strategy for neuroendocrine carcinoma of the lung].
Kawase A; Nagai K
Gan To Kagaku Ryoho; 2009 Oct; 36(10):1619-22. PubMed ID: 19838019
[TBL] [Abstract][Full Text] [Related]
12. [Medical treatment of digestive neuroendocrine tumours].
Panzuto F; Nasoni S; Delle Fave G
Minerva Endocrinol; 2001 Sep; 26(3):145-8. PubMed ID: 11753237
[TBL] [Abstract][Full Text] [Related]
13. A clinicopathologic study of 12 neuroendocrine tumors arising in the thymus.
Tiffet O; Nicholson AG; Ladas G; Sheppard MN; Goldstraw P
Chest; 2003 Jul; 124(1):141-6. PubMed ID: 12853516
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of paclitaxel, carboplatin, and etoposide in advanced poorly differentiated neuroendocrine carcinoma: a Minnie Pearl Cancer Research Network Study.
Hainsworth JD; Spigel DR; Litchy S; Greco FA
J Clin Oncol; 2006 Aug; 24(22):3548-54. PubMed ID: 16877720
[TBL] [Abstract][Full Text] [Related]
15. Use of Molecular Profiling to Guide Treatment Decisions in Patients with Neuroendocrine Tumors: Preliminary Results.
Cutler HS; Ogando P; Uhr JH; Gonzalez DO; Warner RR; Divino CM
Am Surg; 2016 Apr; 82(4):369-75. PubMed ID: 27097632
[TBL] [Abstract][Full Text] [Related]
16. Well-differentiated bronchial neuroendocrine tumors: Clinical management and outcomes in 105 patients.
Pericleous M; Karpathakis A; Toumpanakis C; Lumgair H; Reiner J; Marelli L; Thirlwell C; Caplin ME
Clin Respir J; 2018 Mar; 12(3):904-914. PubMed ID: 28026127
[TBL] [Abstract][Full Text] [Related]
17. Carcinoid tumors of the lung. An analysis of 65 operated cases.
Stefani A; Morandi U; Urgese AL; Rivasi F; Lodi R
J Cardiovasc Surg (Torino); 1999 Aug; 40(4):607-12. PubMed ID: 10532229
[TBL] [Abstract][Full Text] [Related]
18. Clinical management of atypical carcinoid and large-cell neuroendocrine carcinoma: a multicentre study on behalf of the European Association of Thoracic Surgeons (ESTS) Neuroendocrine Tumours of the Lung Working Group†.
Filosso PL; Rena O; Guerrera F; Moreno Casado P; Sagan D; Raveglia F; Brunelli A; Welter S; Gust L; Pompili C; Casadio C; Bora G; Alvarez A; Zaluska W; Baisi A; Roesel C; Thomas PA;
Eur J Cardiothorac Surg; 2015 Jul; 48(1):55-64. PubMed ID: 25406425
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of neuroendocrine tumors of the digestive tract].
Wada I; Shimizu N; Seto Y
Gan To Kagaku Ryoho; 2009 Oct; 36(10):1606-10. PubMed ID: 19838017
[TBL] [Abstract][Full Text] [Related]
20. Amrubicin monotherapy for patients with extrapulmonary neuroendocrine carcinoma after platinum-based chemotherapy.
Nio K; Arita S; Isobe T; Kusaba H; Kohashi K; Kajitani T; Tamura S; Hirano G; Mitsugi K; Makiyama A; Esaki T; Ariyama H; Oda Y; Akashi K; Baba E
Cancer Chemother Pharmacol; 2015 Apr; 75(4):829-35. PubMed ID: 25702050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
